NASDAQ:ADMA

Adma Biologics Stock News

Healthcare > Biotechnology

Buy ADMA

*Your capital is at risk

$8.69

+0.120 (+1.40%)

At Close: Jun 23, 2026

ADMA INVESTIGATION REMINDER: ADMA Biologics Investors are Notified to Contact BFA Law about its Securities Fraud Investigation after Auditor Resigns

03:36pm, Tuesday, 29'th Oct 2024

NEW YORK, NY / ACCESSWIRE / October 29, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ADMA Biologics Inc (ADMA) and Encourages Shareholders to Learn More About the Investigation

10:00am, Tuesday, 29'th Oct 2024

NEW YORK CITY, NY / ACCESSWIRE / October 29, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ADMA Biologics Inc ("ADMA Biologics" or "the Company

ADMA INVESTIGATION NOTICE: ADMA Biologics Stock Plummets 20% after Auditor Resigns; Investors are Notified to Contact BFA Law (Nasdaq:ADMA)

06:34am, Tuesday, 29'th Oct 2024

NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the fe

ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into ADMA Biologics Inc and Encourages Investors to Contact the Firm

04:00pm, Monday, 28'th Oct 2024

NEW YORK--(BUSINESS WIRE)---- $ADMA #ADMA--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ADMA Biologics Inc (“ADMA Biologics�

ADMA INVESTIGATION ALERT: Securities Fraud Investigation into ADMA Biologics after Auditor Resigns is Ongoing; Investors with Losses are Reminded to Contact BFA Law

03:46pm, Monday, 28'th Oct 2024

NEW YORK, NY / ACCESSWIRE / October 28, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the

ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into ADMA Biologics Inc and Encourages Investors to Contact the Firm

04:00pm, Sunday, 27'th Oct 2024

NEW YORK, Oct. 27, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ADMA Biologics Inc (“ADMA Biologics�

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA

12:00pm, Sunday, 27'th Oct 2024

NEW YORK, NY / ACCESSWIRE / October 27, 2024 / Pomerantz LLP is investigating claims on behalf of investors of ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ:ADMA). Such investors are advised

Bronstein, Gewirtz & Grossman, LLC Encourages ADMA Biologics Inc (ADMA) Shareholders to Inquire about Securities Investigation

10:00am, Sunday, 27'th Oct 2024

NEW YORK CITY, NY / ACCESSWIRE / October 27, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ADMA Biologics Inc ("ADMA Biologics" or "the Company

ADMA FRAUD ALERT: BFA Law Notifies ADMA Biologics Investors of Ongoing Securities Fraud Investigation after Auditor Resigns and Urges You to Contact the Firm (Nasdaq:ADMA)

08:06am, Sunday, 27'th Oct 2024

NEW YORK, Oct. 27, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ: ADMA) for potential violations of the f

ADMA FRAUD NEWS: ADMA Biologics Investigated for Securities Fraud after Auditor Abruptly Resigns; Investors with Losses Urged to Contact BFA Law

07:33am, Saturday, 26'th Oct 2024

NEW YORK, NY / ACCESSWIRE / October 26, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA

11:00am, Friday, 25'th Oct 2024

NEW YORK , Oct. 25, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA). Such investors are advised to

ADMA LEGAL NEWS: ADMA Biologics Investigated for Securities Fraud after Stock Drops 20%; Investors with Losses are Urged to Contact BFA Law (Nasdaq:ADMA)

06:06am, Friday, 25'th Oct 2024

NEW YORK, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ: ADMA) for potential violations of the f

ADMA LEGAL NOTICE: BFA Law Encourages ADMA Biologics Investors that Lost Money to Contact the Firm about Securities Fraud Investigation into Auditor Resignation

03:34pm, Thursday, 24'th Oct 2024

NEW YORK, NY / ACCESSWIRE / October 24, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA

04:30pm, Wednesday, 23'rd Oct 2024

NEW YORK, NY / ACCESSWIRE / October 23, 2024 / Pomerantz LLP is investigating claims on behalf of investors of ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ:ADMA). Such investors are advised

ADMA INVESTOR ALERT: ADMA Biologics Investors that Suffered Losses are Alerted to Contact BFA Law about Securities Fraud Investigation into Auditor Resignation (Nasdaq:ADMA)

03:44pm, Wednesday, 23'rd Oct 2024

NEW YORK, NY / ACCESSWIRE / October 23, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by